Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Int J Pharm ; 659: 124219, 2024 Jun 25.
Article de Anglais | MEDLINE | ID: mdl-38734277

RÉSUMÉ

This work aimed at formulating a trilaminate dressing loaded with tranexamic acid. It consisted of a layer of 3 % sodium hyaluronate to initiate hemostasis. It was followed by a mixed porous layer of 5 % polyvinyl alcohol and 2 % kappa-carrageenan. This layer acted as a drug reservoir that controlled its release. The third layer was 5 % ethyl cellulose backing layer for unidirectional release of tranexamic acid towards the wound. The 3 layers were physically crosslinked by hydrogen bonding as confirmed by Infrared spectroscopy. Swelling and release studies were performed, and results proposed that increasing number of layers decreased swelling properties and sustained release of tranexamic acid for 8 h. In vitro blood coagulation study was performed using human blood and showed that the dressing significantly decreased coagulation time by 70.5 % compared to the negative control. In vivo hemostatic activity was evaluated using tail amputation model in Wistar rats. Statistical analysis showed the dressing could stop bleeding in a punctured artery of the rat tail faster than the negative control by 59 %. Cranial bone defect model in New Zealand rabbits was performed to check for bone hemostasis and showed significant decrease in the hemostatic time by 80 % compared to the control.


Sujet(s)
Bandages , Carragénane , Hémorragie , Acide hyaluronique , Poly(alcool vinylique) , Rat Wistar , Acide tranéxamique , Animaux , Lapins , Hémorragie/traitement médicamenteux , Hémorragie/prévention et contrôle , Poly(alcool vinylique)/composition chimique , Acide tranéxamique/composition chimique , Acide tranéxamique/administration et posologie , Acide hyaluronique/composition chimique , Humains , Cellulose/analogues et dérivés , Cellulose/composition chimique , Mâle , Modèles animaux de maladie humaine , Rats , Libération de médicament , Coagulation sanguine/effets des médicaments et des substances chimiques , Antifibrinolytiques/composition chimique , Antifibrinolytiques/administration et posologie , Antifibrinolytiques/pharmacologie , Hémostatiques/composition chimique , Hémostatiques/pharmacologie , Hémostatiques/administration et posologie , Préparations à action retardée
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE